feed,title,long_url,short_url
Benzinga,Kura Oncology Presents First Clinical Data for Menin Inhibitor KO-539 at American Society of Hematology Annual Meeting,https://www.benzinga.com/pressreleases/20/12/g18663390/kura-oncology-presents-first-clinical-data-for-menin-inhibitor-ko-539-at-american-society-of-hemat,https://j.mp/39MAHNs
Benzinga,Allogene Therapeutics Reports Positive Initial Results from Phase 1 UNIVERSAL Study of ALLO-715 AlloCAR Tâ„¢ Cell Therapy in Relapsed/Refractory Multiple Myeloma at the 62nd American Society of Hematology Annual Meeting,https://www.benzinga.com/pressreleases/20/12/g18663389/allogene-therapeutics-reports-positive-initial-results-from-phase-1-universal-study-of-allo-715-al,https://j.mp/2Lc21KQ
